Study in Pediatric Subjects With Epilepsy

NCT01494584 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated after placing the study on hold at the request of the FDA

Conditions

Epilepsy

Interventions

DRUG: ezogabine/retigabine

Sponsor

GlaxoSmithKline

Collaborators

[object Object]